Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset - HMS LINCS Database

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells	Antibodies

|<
<<
Previous
Page 250 of 3330
Next
>>
>
6226 to 6250 of 83232 records
per page:

Cell	Clinical Subtype	Transcriptional Subtype	Small Molecule	Perturbagen Target	Perturbagen Class	Perturbagen Concentration	Perturbagen Conc Unit	Biological Replicate ID	Relative Cell Count	Normalized Growth Rate Inhibition Value	Nominal Division Rate
MCF 10F	NM	-	AG1478	EGFR	ErbB	6.67	uM	7872.016	0.4156	0.1065	1.4834
MCF 10F	NM	-	AG1478	EGFR	ErbB	33.3	uM	7872.016	0.4050	0.0875	1.4834
MCF 10F	NM	-	AG1478	EGFR	ErbB	167	uM	7872.016	0.2917	-0.1284	1.4834
MCF12A	NM	Basal B	AG1478	EGFR	ErbB	0.000427	uM	7491.016	0.9927	0.9781	0.6625
MCF12A	NM	Basal B	AG1478	EGFR	ErbB	0.00213	uM	7491.016	0.9478	0.8446	0.6625
MCF12A	NM	Basal B	AG1478	EGFR	ErbB	0.0107	uM	7491.016	0.9601	0.8807	0.6625
MCF12A	NM	Basal B	AG1478	EGFR	ErbB	0.0533	uM	7491.016	0.8539	0.5757	0.6625
MCF12A	NM	Basal B	AG1478	EGFR	ErbB	0.267	uM	7491.016	0.5912	-0.0955	0.6625
MCF12A	NM	Basal B	AG1478	EGFR	ErbB	1.33	uM	7491.016	0.3012	-0.6731	0.6625
MCF12A	NM	Basal B	AG1478	EGFR	ErbB	6.67	uM	7491.016	0.3032	-0.6698	0.6625
MCF12A	NM	Basal B	AG1478	EGFR	ErbB	33.3	uM	7491.016	0.1906	-0.8362	0.6625
MCF12A	NM	Basal B	AG1478	EGFR	ErbB	167	uM	7491.016	0.1533	-0.8820	0.6625
MCF12A	NM	Basal B	AG1478	EGFR	ErbB	0.000427	uM	7873.016	0.9698	0.9717	2.1516
MCF12A	NM	Basal B	AG1478	EGFR	ErbB	0.00213	uM	7873.016	0.9573	0.9599	2.1516
MCF12A	NM	Basal B	AG1478	EGFR	ErbB	0.0107	uM	7873.016	0.9899	0.9906	2.1516
MCF12A	NM	Basal B	AG1478	EGFR	ErbB	0.0533	uM	7873.016	1.0337	1.0310	2.1516
MCF12A	NM	Basal B	AG1478	EGFR	ErbB	0.267	uM	7873.016	0.9533	0.9560	2.1516
MCF12A	NM	Basal B	AG1478	EGFR	ErbB	1.33	uM	7873.016	0.3681	0.2569	2.1516
MCF12A	NM	Basal B	AG1478	EGFR	ErbB	6.67	uM	7873.016	0.2579	0.0653	2.1516
MCF12A	NM	Basal B	AG1478	EGFR	ErbB	33.3	uM	7873.016	0.4513	0.3818	2.1516
MCF12A	NM	Basal B	AG1478	EGFR	ErbB	167	uM	7873.016	0.2682	0.0848	2.1516
MCF7	HR+	Luminal	AG1478	EGFR	ErbB	0.000427	uM	7874.016	0.8695	0.8321	1.5947
MCF7	HR+	Luminal	AG1478	EGFR	ErbB	0.00213	uM	7874.016	0.9696	0.9616	1.5947
MCF7	HR+	Luminal	AG1478	EGFR	ErbB	0.0107	uM	7874.016	0.9708	0.9632	1.5947
MCF7	HR+	Luminal	AG1478	EGFR	ErbB	0.0533	uM	7874.016	0.9799	0.9747	1.5947

|<
<<
Previous
Page 250 of 3330
Next
>>
>
6226 to 6250 of 83232 records
per page:

HMS LINCS Project

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)